Mechanistic Insights and Perspectives on AVL9-Mediated Chemoresistance in Pancreatic Ductal Adenocarcinoma. Tang X, Xu J, Ran Q, Zhang Y, et al. Gastroenterology 2025 May 15:S0016-5085(25)00757.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tang X, Xu J, Ran Q, Zhang Y, et al. Mechanistic Insights and Perspectives on AVL9-Mediated Chemoresistance in Pancreatic Ductal Adenocarcinoma. Gastroenterology 2025 May 15:S0016-5085(25)00757.
PMID: 40381957